Carmen D. Schweighofer

A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia

K. Coombes, L. Medeiros, L. Abruzzo, 2011, PloS one.

Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features.

L. Medeiros, L. Abruzzo, M. Keating, 2011, American journal of clinical pathology.

LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.

K. Coombes, B. Czerniak, Tadeusz Majewski, 2011, Blood.

The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy

L. Medeiros, L. Abruzzo, M. Keating, 2011, International journal of cancer.